Skip to main content
Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0040
0.00 (0.00%)
At close: Dec 3, 2025

Diagonal Bio AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
1.391.133.153.718.678
Revenue Growth (YoY)
15.12%-64.30%-14.98%-57.26%8.41%-
Cost of Revenue
0.440.180.021.658.768.07
Gross Profit
0.960.943.132.05-0.09-0.07
Selling, General & Admin
9.239.3614.6817.2211.550.74
Other Operating Expenses
0.01-00.02-00.03-0.03
Operating Expenses
10.4610.3614.717.2211.580.71
Operating Income
-9.5-9.42-11.57-15.16-11.66-0.78
Interest Expense
-0.01-0.58-0.21-1--
Interest & Investment Income
0.070.080.09---
Other Non Operating Income (Expenses)
0-0---
Pretax Income
-9.44-9.93-11.68-16.16-11.66-0.78
Net Income
-9.44-9.93-11.68-16.16-11.66-0.78
Net Income to Common
-9.44-9.93-11.68-16.16-11.66-0.78
Shares Outstanding (Basic)
1,02727636974
Shares Outstanding (Diluted)
1,02727636974
Shares Change (YoY)
438.78%655.26%284.00%38.15%96.47%-
EPS (Basic)
-0.01-0.04-0.32-1.70-1.70-0.22
EPS (Diluted)
-0.01-0.04-0.32-1.70-1.70-0.22
Gross Margin
68.77%83.73%99.43%55.42%-0.98%-0.87%
Operating Margin
-682.27%-837.42%-367.09%-409.15%-134.52%-9.72%
Profit Margin
-677.89%-882.67%-370.61%-436.16%-134.52%-9.72%
EBITDA
-9.09-9.23-11.56---
D&A For EBITDA
0.410.190---
EBIT
-9.5-9.42-11.57-15.16-11.66-0.78
EBIT Margin
-----134.52%-9.72%
Revenue as Reported
1.391.133.183.738.728.12
Source: S&P Capital IQ. Standard template. Financial Sources.